PLOS Medicine Response to Reviewers: How to Write a Rebuttal That Wins (2026)
How to write a point-by-point response to reviewers for PLOS Medicine, where a staff editor and Academic Editor co-decide, major revisions trigger statistical re-review, and the CONSORT/PRISMA/STROBE and data-availability bar follows you into the rebuttal.
Readiness scan
Before you submit to PLOS Medicine, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
PLOS Medicine at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 12.4 puts PLOS Medicine in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~~15% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: PLOS Medicine takes ~6-8 weeks. A faster-turnaround journal may suit a grant or job deadline better.
- If OA is required: gold OA costs $5,900 USD. Check institutional agreements before submitting.
How to use this page well
These pages work best when they behave like tools, not essays. Use the quick structure first, then apply it to the exact journal and manuscript situation.
Question | What to do |
|---|---|
Use this page for | Building a point-by-point response that is easy for reviewers and editors to trust. |
Start with | State the reviewer concern clearly, then pair each response with the exact evidence or revision. |
Common mistake | Sounding defensive or abstract instead of specific about what changed. |
Best next step | Turn the response into a visible checklist or matrix before you finalize the letter. |
Quick answer: A PLOS Medicine response to reviewers is a point-by-point rebuttal co-decided by a professional staff editor and the same Academic Editor, with statistical re-review likely on a major revision. Open with a short letter to the editor, answer each comment under Reviewer 1, Reviewer 2, and the Academic Editor's note, and give the page and line number to cite for every change.
Carry the clinical reporting bar into the rebuttal: a complete CONSORT, PRISMA, or STROBE checklist and a compliant data-availability statement (never "available on request" for most studies). Upload it all through Editorial Manager.
Start with the PLOS Medicine rebuttal readiness check before you resubmit, or work through this guide by hand. For broader cluster context, see the PLOS Medicine journal overview.
What does a PLOS Medicine response to reviewers require?
The Manusights PLOS Medicine rebuttal scan. This guide tells you what the staff editor, the Academic Editor, and the reviewers look for in a PLOS Medicine rebuttal. The scan tells you whether YOUR response letter passes that check before you upload it through Editorial Manager (editorialmanager.com/pmedicine). We have reviewed manuscripts and rebuttals targeting PLOS Medicine and peer clinical and public-health venues; the patterns below are the same ones reviewers flag at re-review. We do not train AI on your manuscript and delete it within 24 hours.
Three things make a PLOS Medicine rebuttal different from a generic one:
- It is co-decided. Each submission is handled by a professional in-house staff editor and an Academic Editor. On revision, "revised manuscripts will be assessed by a professional editor and the same Academic Editor," so your letter answers two readers with different priorities.
- A major revision can trigger statistical re-review. PLOS Medicine states that "manuscripts that undergo major revision may require re-review or additional statistical review." A reanalysis comment is answered with numbers, not reassurance.
- The clinical reporting bar follows you into the rebuttal. The CONSORT, PRISMA, STROBE, or STARD checklist, prospective trial registration, and the strict data-availability statement are all re-checked on revision, not just at first submission.
How we built this guide: we read PLOS Medicine's own editorial-process, reviewer, data-availability, and submission pages, cross-checked them against the cross-PLOS responding-to-peer-review resource and SciRev community reports, and set all of it against our own pre-submission reviews of PLOS Medicine rebuttals. Every claim below traces to a primary source or our review corpus.
Use this guide to pressure-test the response letter before you submit the revision. The stakes are concrete. Under PLOS Community Action Publishing, a Research Article from a non-member institution carries a non-member fee of $5,500, and a revised abstract still has to come in under the 300-word target (500-word maximum). Getting the revision right on the first attempt is the cheapest version of this.
Element | What PLOS Medicine expects | What reviewers flag at re-review |
|---|---|---|
Structure | Editor letter, then point-by-point under each reviewer and the Academic Editor note | Free-form prose answering all comments together |
Reporting rigor | Complete CONSORT, PRISMA, or STROBE checklist with page and line for each item | Checklist where half the items say "see Methods" or are blank |
Statistics | Actual reanalysis and numbers for a sample-size or model concern | "We have clarified the analysis in the text" with no new output |
Data availability | Repository deposit or named ethics or data-access committee contact | "Data available from the authors on request" |
Specificity | Page and line number for every manuscript change | "We have updated the manuscript" with no location |
Tone | Substantive on science, gracious on style, claims narrowed to the data | Overstating clinical or policy implications to deflect a concern |
Source: PLOS Medicine editorial-process, reviewer, and data-availability documentation, accessed June 2026.
The copyable PLOS Medicine rebuttal template
The staff editor, the Academic Editor, and the reviewers all read your response, and PLOS asks you to keep it "clear, unemotional, and easy to follow." A clean, scannable structure does real work. Copy this skeleton, then replace the bracketed text with your own changes. Keep the reviewer text and your reply in two distinct fonts or colors, and submit it through Editorial Manager with a tracked-changes file.
Dear Editor,
Thank you for the opportunity to revise our manuscript the manuscript title
(PMEDICINE-[ID]). We are grateful to the Academic Editor and the
reviewers for their careful reports. In response, we have [reanalyzed
the primary outcome / added the sensitivity analysis], completed the
[CONSORT / STROBE / PRISMA] checklist with page and line references,
and updated the Data Availability statement to name a repository. A
point-by-point response follows; reviewer comments are in bold and our
replies in plain text, with revised-manuscript page and line numbers
given for every change.
----------------------------------------------------------------
Academic Editor
Comment E.1: "Please ensure the reporting checklist is complete and
references specific locations in the manuscript."
Response: We have completed the [CONSORT] checklist; every item now
cites a page and line in the revised manuscript (uploaded as
Supporting Information S1 Checklist). See, for example, randomization
on page 8, lines 4 to 11.
----------------------------------------------------------------
Reviewer 1
Comment 1.1: "The sample-size justification and the model
specification are unclear."
Response: We agree. We have added the power calculation (Methods,
page 9, lines 2 to 14) and re-run the primary analysis with the
prespecified model; the effect estimate is [value, 95% CI]. See
page 12, lines 3 to 9, and Table 2.
Comment 1.2: "The clinical implications are overstated for a single-
center study."
Response: We have narrowed the implication to what the data support
and added the generalizability limitation. Revised text is on
page 16, lines 8 to 17.
----------------------------------------------------------------
Reviewer 2
Comment 2.1: "The data availability statement says data are available
on request."
Response: We have deposited the de-identified dataset at [repository,
accession number] and revised the Data Availability statement. Where
access is restricted, the named contact is the [institutional data-
access committee], not an individual author. See page 21, lines 1 to 5.
We believe the revised manuscript now addresses each comment and we
look forward to your decision.
Sincerely,
[Corresponding author, on behalf of all authors]This skeleton carries the four things a PLOS Medicine staff editor and Academic Editor scan for when they reopen your file:
- A short letter to the editor that names the major changes up front.
- A per-reviewer and Academic Editor structure, with the Academic Editor's note answered as its own block.
- Explicit action language ("we have added", "we have reanalyzed", "we have deposited"), not "we believe" or "we feel".
- A page and line reference in the revised file for every change you claim.
The page-and-line rule: cite the location of every change
State the exact page and line number for each manuscript revision, and name the specific figure, table, Supporting Information file, or checklist item you touched. PLOS itself tells authors to "indicate line numbers in your response where the requested change can be found," so this is not optional polish at PLOS Medicine.
It is also the single most-cited rebuttal failure here and across clinical journals.A reviewer who has to hunt for your change reads it as evasion. A reviewer who can jump straight to page 8, lines 4 to 11, and see the randomization detail finishes faster and re-reviews more favorably.
Two PLOS-specific habits keep your citations verifiable:
- Number against the revised file, not the original. Line numbers shift between rounds; cite the version the reviewer is now reading.
- Flag where the change actually lives. Say when an edit is in the S1 Checklist or a Supporting Information file rather than the main text, since at PLOS the checklist and the data statement are re-audited separately.
The one rule never to break
Never write "we have addressed this in the manuscript" without a page and line. At PLOS Medicine the same single-blind reviewer who re-reads your revision compares each reply against their original comment, and a missing location is the first thing they notice.
Reviewer-text vs author-response typography
Make the reviewer's words and your reply visually distinct. Put each reviewer comment in bold or a colored text box, and keep your response in plain regular text directly beneath it.
The staff editor, the Academic Editor, and the reviewers scan many of these letters in a sitting. A rebuttal where comment and reply blur into one block costs you the attention you need most.
This layout earns its keep at PLOS Medicine specifically. Because review is single-blind and the same reviewer is often asked to re-read your revision, they work down their original report comment by comment, checking each one off against your reply. A clean two-color or two-font block is the difference between a document they can follow and one they skim past.
Tone calibration: how to phrase the hard replies
The reviewers and the Academic Editor see your tone across every comment, and PLOS reminds authors that "the editor and reviewers will see everything you write." A defensive reply to one reviewer is visible to all of them. The trap unique to a clinical journal is using the rebuttal to harden a clinical claim rather than narrow it. Calibrate.
Bad (defensive, vague, or overstated) | Better (substantive, gracious, narrowed) |
|---|---|
"The reviewer has misunderstood our analysis." | "We did not describe the model clearly; we have rewritten the Statistical Analysis section on page 9 and re-run the primary analysis." |
"Our findings have broad clinical implications." | "We have narrowed the clinical implication to the studied population and added the generalizability limitation on page 16, lines 8 to 17." |
"We have addressed the reporting concern." | "We have completed the CONSORT checklist; each item now cites a page and line (S1 Checklist), e.g., blinding on page 8, lines 12 to 18." |
"The data are available from the authors on request." | "We have deposited the de-identified dataset at [repository, accession number] and named the institutional data-access committee as the contact for restricted variables (page 21, lines 1 to 5)." |
"This sensitivity analysis is outside our scope." | "We agree it strengthens the work and have added it (Table S3); the primary estimate is unchanged (page 13, lines 4 to 10)." |
"The other reviewer did not raise this point." | "We appreciate this point and have added the prespecified subgroup analysis to resolve it; see page 14, lines 2 to 9." |
The pattern that works: concede where the reviewer is right, do the work, point to the exact change, narrow the claim to the data, and push back only on a request that is genuinely out of scope, with a reason and an alternative.
The PLOS Medicine reviewer culture you are writing into
Who decides, and what the decision words mean
PLOS Medicine runs a co-edited model. Every initial submission "is assigned to a PLOS Medicine staff editor for an assessment of scope and quality," and the professional editor and the Academic Editor jointly decide whether to invite review, what a revision must contain, and the final outcome. On revision, "revised manuscripts will be assessed by a professional editor and the same Academic Editor," so the editor who already knows your file does not change between rounds. External review is single-blind: reviewers stay anonymous unless they self-identify.
Decisions come in four words: Reject, Major revision, Minor revision, Accept. The journal states that "if after peer review a manuscript is considered potentially appropriate for PLOS Medicine, a major revision is generally requested," with a minor revision reserved as the last step before acceptance. So a major-revision letter is the journal's normal vote of confidence, not a near-acceptance you can answer lightly.
What the reviewers are actually graded against
The defining features for the rebuttal are reporting rigor and statistics. PLOS Medicine reviewers are asked whether "the data and analyses fully support the claims," whether the methodology is "sufficient to allow the experiments to be reproduced," whether the work follows "relevant guidelines such as CONSORT, MIAME, QUORUM, STROBE," and whether the article is "of interest to clinicians and policymakers who are not specialists in this topic."
On a major revision, the journal warns that re-review "may require... additional statistical review." A sample-size, model, or analysis comment is therefore answered by a statistical reviewer reading your reanalysis, not by the handling editor taking your word for it. The clinical-significance and reproducibility bar that earned you a revise verdict carries straight into the rebuttal.
For planning, SciRev community reports (a small, author-reported sample) put a first review round at roughly six to seven weeks, with a fair share of submissions rejected outright at the staff-editor stage. That second number is a reminder: a revise verdict already cleared a heavy filter.
How PLOS Medicine differs from the journals around it
The rebuttal you write depends on the room you are writing into:
- At basic-science flagships (Nature, Cell), you face a novelty-first bar and a mechanism-depth reviewer.
- At general medical journals like The Lancet or JAMA, the rebuttal is routed past a dedicated statistical reviewer and a clinical-relevance editor.
- At PLOS Medicine, the rigor bar matches the clinical journals (CONSORT, PRISMA, STROBE, prospective trial registration, strict open data), but an Academic Editor is paired with a professional staff editor and the article publishes open access.
Because those reporting and data standards are non-negotiable, a PLOS Medicine rebuttal reads more like clearing a methods-and-transparency audit than winning a novelty argument. That is not true at journals where the reviewer's first question is "is this new enough."
Key Insight
At PLOS Medicine the rebuttal is graded on rigor, not rhetoric. A reanalysis with numbers, a complete reporting checklist tied to page and line, and a compliant data statement beat any amount of polished prose defending the original claim.
What our PLOS Medicine rebuttal reviews surface
In our pre-submission review work with PLOS Medicine manuscripts, the rebuttals that stall in a second revision round share a small set of recurring weaknesses. These are the same ones reviewers and the statistical reviewer flag at re-review, and each maps to a specific, named failure pattern in the journal's clinical-rigor culture. Each is testable against your own draft response before you upload it.
Answering a reporting-standard request with a partial checklist. The most common and most expensive pattern in our PLOS Medicine pre-submission reviews is a rebuttal that "completes" the CONSORT or STROBE checklist but leaves half the items pointing only to "see Methods" or blank. PLOS Medicine staff editors check checklist completeness on revision, and a reviewer who asked for full reporting reads a half-filled checklist as non-compliance, not as a good-faith fix.
Across our PLOS Medicine rebuttal reviews, a checklist where every item cites a real page and line in the revised manuscript is the single strongest signal that the author took the reporting comment seriously.
Overstating clinical implications to deflect a generalizability concern. Because PLOS Medicine wants work "of interest to clinicians and policymakers," authors sometimes answer a generalizability or external-validity comment by hardening the clinical-implication language rather than narrowing the claim. In our PLOS Medicine pre-submission reviews this backfires: the reviewer asked you to bound the claim to what the data support, and a bigger claim reads as a refusal. The fix is to narrow the implication, add the generalizability limitation, and cite the exact page and line where you did it.
An "available on request" data statement PLOS rejects. PLOS journals require authors to make the data underlying their findings available without restriction, and "data available from the authors on request" is not acceptable for most studies. In our pre-submission review work with PLOS Medicine manuscripts, a rebuttal that answers a data-availability comment with a generic on-request statement draws an immediate re-review block.
For restricted human-participant or clinical data, the compliant answer is a controlled-access repository deposit or a named ethics or data-access committee as the contact, never a single author, with the revised Data Availability statement cited by page and line.
Inconsistent answers to a shared statistical concern. Because a major revision can trigger additional statistical review, a rebuttal that frames the same sample-size or model concern one way for Reviewer 1 and another way for Reviewer 2 reads as evasive and invites a deeper statistical re-read. In our PLOS Medicine pre-submission reviews we routinely find an analysis concern raised by two reviewers and answered with two different numbers or two different justifications. Reconcile every overlapping comment to a single, consistent reanalysis before submission.
Complete the checklist, narrow the claim, deposit the data, and reconcile the statistics. That four-part discipline is what separates a PLOS Medicine rebuttal that clears one revision round from one that stalls into a second or a rejection. Check your PLOS Medicine point-by-point response for these patterns before you submit.
Readiness check
Run the scan while PLOS Medicine's requirements are in front of you.
See how this manuscript scores against PLOS Medicine's requirements before you submit.
When to comply and when to push back
Situation | Recommended approach at PLOS Medicine |
|---|---|
Reviewer asks for a reanalysis or sensitivity analysis | Comply. Run it, report the numbers and 95% CI, cite the page and line. |
Academic Editor flags an incomplete reporting checklist | Comply. Complete CONSORT, PRISMA, or STROBE and tie each item to a page and line. |
Reviewer questions data availability | Comply. Deposit in a repository or name an institutional contact; never "on request." |
Reviewer flags an overstated clinical implication | Comply. Narrow the claim to the studied population; add the limitation. |
Reviewer asks for an analysis genuinely out of scope | Push back with a reason, add the closest feasible analysis, note the open question. |
Two reviewers raise the same statistical point | Engage once, consistently; remember a statistical reviewer may re-read it. |
Source: Manusights pre-submission reviews of PLOS Medicine-targeted resubmissions, 2025 cohort.
How much work a PLOS Medicine rebuttal actually takes
Authors consistently underestimate the reporting-and-data effort and overestimate the writing effort. This breakdown is about workload, not the journal's decision clock; for the end-to-end schedule, see the PLOS Medicine submission process guide.
Rebuttal task | Where the effort goes | What it costs you |
|---|---|---|
Reading and clustering the reviewer and Academic Editor reports | Finding the one core concern behind the comments | A day of careful reading, not a skim |
Reanalysis or new sensitivity analyses | The real bar when statistics are questioned | The bulk of the work, often a week or more |
Completing the reporting checklist to page and line | CONSORT, PRISMA, or STROBE tied to the revised file | Tedious but decisive; staff editors check it |
Fixing the data-availability statement | Repository deposit or named institutional contact | Underestimated; arrange access before you reply |
Writing the point-by-point replies | One reply plus a page and line per comment | Less than authors fear once the work is done |
Source: Manusights pre-submission reviews of PLOS Medicine resubmissions, 2025 cohort, last updated June 6, 2026.
Honest friction: rejection on revision is real
A major-revision invitation at PLOS Medicine is not a soft acceptance. The revised manuscript and your point-by-point response go back to a professional editor and the same Academic Editor, often to the original reviewers, and on a major revision possibly to a statistical reviewer. The paper can still end in rejection after re-review if the revision does not resolve the core concern.
PLOS Medicine staff editors also reject a substantial share of submissions outright before review, so the journal does not rubber-stamp revisions either. Most rejections at the revision stage trace to one cause: the author answered a substantive request (a reanalysis, a complete reporting checklist, or a compliant data statement) with wording changes. The runner-up cause is an inconsistent answer to a statistical point raised by more than one reviewer.
Think twice before you resubmit if any of these are true:
- The response leans on generic "we have addressed this" language with no page or line numbers.
- A reviewer asked for a reanalysis and you answered with text.
- The reporting checklist is half-filled or points only to "see Methods."
- The Data Availability statement still says "on request."
- The same statistical comment from two reviewers got two different answers.
Fixing these before resubmission is what keeps a second round from becoming a rejection.
Red flags a PLOS Medicine reviewer spots in seconds
Before you upload, scan your own rebuttal for the patterns that draw an immediate re-review comment. Each is a specific, checkable thing in your draft, not a vague quality dimension.
- A reply with no location. Any "we have revised the manuscript" with no page and line number reads as evasion the moment a reviewer cannot find the change.
- A half-filled reporting checklist. A CONSORT or STROBE checklist where items say only "see Methods" or are blank signals the reporting comment was not really addressed.
- An on-request data statement. "Data available from the authors on request" is non-compliant for most studies and stops re-review until it is fixed.
- A hardened clinical claim. Answering a generalizability concern by overstating the clinical or policy implication, rather than narrowing it, reads as a refusal.
- Two answers to one statistical point. The same sample-size or model concern raised by two reviewers, answered two different ways, invites a deeper statistical re-read.
How does this guide go beyond the PLOS Medicine author guidelines?
The official guidelines tell you to submit a point-by-point response, to keep it clear and unemotional, and to indicate line numbers for each change. What they leave out is the part that changes how you write every reply:
- A staff editor and the same Academic Editor co-decide your revision, so you are answering two readers at once.
- A major revision can trigger a separate statistical re-review, so a numbers comment needs numbers back.
- The reporting checklist and data-availability statement are re-audited on revision, not waved through from round one.
- Watch the tone: overstating a clinical claim to deflect a concern is the fastest route to a second round.
Those patterns come from our pre-submission reviews of PLOS Medicine rebuttals. They are testable against your own draft today, not theoretical concerns.
- Manusights pre-submission reviews of PLOS Medicine-targeted manuscripts (2025 cohort)
Frequently asked questions
Open with a short letter to the editor summarizing the major changes, then answer every comment in order under Reviewer 1, Reviewer 2, and the Academic Editor's note. Quote each comment in full, state the exact change you made, and give the page and line number in the revised manuscript. Submit it through Editorial Manager alongside the tracked-changes file. PLOS asks you to keep responses clear, unemotional, and easy to follow, because the editor and all reviewers see everything you write.
Often, yes. PLOS Medicine states that manuscripts undergoing major revision may require re-review or additional statistical review. If a reviewer or the Academic Editor raised a sample-size, analysis, or model-specification concern, expect a statistical reviewer to look at your revised analysis. Answer the statistics comment with the actual reanalysis and the numbers, not with reassurance, and reconcile the answer across every reviewer who raised it.
Upload the completed reporting checklist for your study type and make sure every checklist item points to a real page and line in the revised manuscript. Use CONSORT for randomized trials, PRISMA for systematic reviews, STROBE for observational studies, and STARD for diagnostic-accuracy studies. A checklist where half the items say only 'see Methods' or are left blank reads as non-compliance, and PLOS Medicine staff editors check completeness before re-review.
Usually not. PLOS journals require you to make the data underlying your findings available without restriction. 'Available from the authors on request' is rejected for most studies. For restricted clinical or human-participant data, deposit in a controlled repository or name a data-access committee or ethics committee as the contact, never the author alone. Update the Data Availability statement in your revision and point the reviewer to it by page and line.
Yes. A major-revision invitation is not an acceptance. The revised manuscript and your response go back to a professional editor and the same Academic Editor, often to the original reviewers, and sometimes to a statistical reviewer. If the revision does not resolve the core concern, or if the reporting or data-availability gaps remain, the paper can be rejected after re-review. Most rejections at this stage trace to answering a substantive request with wording changes.
Sources
- Editorial and Peer Review Process, PLOS Medicine (accessed June 2026)
- Guidelines for Reviewers, PLOS Medicine (accessed June 2026)
- Data Availability, PLOS Medicine (accessed June 2026)
- Submission Guidelines, PLOS Medicine (accessed June 2026)
- How to receive and respond to peer review feedback, PLOS (accessed June 2026)
- Ten simple rules for writing a response to reviewers, William Stafford Noble, PLOS Computational Biology (accessed June 2026)
- Reviews for PLOS Medicine, SciRev (accessed June 2026)
Final step
Submitting to PLOS Medicine?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Target journal carried over: PLOS Medicine
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- PLOS Medicine Submission Guide: What to Prepare Before You Submit
- How to Avoid Desk Rejection at PLOS Medicine
- PLOS Medicine Review Time: What Authors Can Actually Expect
- Rejected from PLOS Medicine? The 7 Best Journals to Submit Next
- PLOS Medicine Submission Process: What Happens After Your Initial Submission
- PLOS Medicine 'Under Review': What Each Status Means and When to Expect a Decision
Supporting reads
Conversion step
Submitting to PLOS Medicine?
Anthropic Privacy Partner. Zero-retention manuscript processing.